User profiles for Alina S. Shomuradova

Alina Shomuradova

DPhil student, University of Oxford
Verified email at path.ox.ac.uk
Cited by 232

[PDF][PDF] SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T cell receptors

AS Shomuradova, MS Vagida, SA Sheetikov… - Immunity, 2020 - cell.com
Understanding the hallmarks of the immune response to SARS-CoV-2 is critical for fighting
the COVID-19 pandemic. We assessed antibody and T cell reactivity in convalescent COVID-…

[HTML][HTML] Clonal structure and the specificity of vaccine-induced T cell response to SARS-CoV-2 Spike protein

…, KV Zornikova, IV Zvyagin, AS Shomuradova… - Frontiers in …, 2024 - frontiersin.org
Adenovirus vaccines, particularly the COVID-19 Ad5-nCoV adenovirus vaccine, have emerged
as promising tools in the fight against infectious diseases. In this study, we investigated …

Amino acids at position 5 in the peptide/MHC binding region of a public virus‐specific TCR are completely inter‐changeable without loss of function

…, L Hageman, AS Shomuradova… - European Journal of …, 2022 - Wiley Online Library
Anti‐viral T‐cell responses are usually directed against a limited set of antigens, but often
contain many T cells expressing different T‐cell receptors (TCRs). Identical TCRs found within …

SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T-cell receptors (preprint)

AS Shomuradova, MS Vagida, SA Sheetikov… - 2020 - pesquisa.bvsalud.org
Understanding the hallmarks of the adaptive immune response to SARS-CoV-2 is critical for
fighting the COVID-19 pandemic. We assessed the antibody and T-cell reactivity in COVID-…

Clonal structure and epitope specificity of Ad5-nCoV vaccine-induced T cell response to SARS-CoV-2

…, IV Zvyagin, AS Shomuradova… - The Journal of …, 2022 - journals.aai.org
As a part of phase 3 clinical trial of a single-dose adenoviral COVID-19 vaccine, we
evaluated the dynamics and clonal structure of T cell response to the SARS-CoV-2 Spike …

[HTML][HTML] Development of T-Cell Therapy Targeting Hematopoietic Minor Histocompatibility Antigen HA-1

…, A Shmelev, N Bykova, A Shomuradova… - Blood, 2019 - Elsevier
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is currently the only curative
therapy for hematological malignancies yet in nearly one-third of patients, it is followed by a …

[HTML][HTML] Immunogenic epitope panel for accurate detection of non-cross-reactive T cell response to SARS-CoV-2

…, NT Shakirova, DB Malko, M Shkurnikov, S Nersisyan… - JCI insight, 2022 - ncbi.nlm.nih.gov
S protein, Alina Shomuradova for help in peptide selection and valuable comments, Murad
Vagida for developing flow cytometry panel for clinical trials, Iuliia Peshkova for help with …

Mutational pressure drives enhanced release of proteasome-generated public CD8+ T cell epitopes from SARS-CoV-2 RBD of Omicron and its current lineages

AA Kudriaeva, IO Butenko, GA Saratov, M Ri… - medRxiv, 2024 - medrxiv.org
The COVID-19 pandemic was the most dramatic in the newest history with nearly 7 million
deaths and global impact on mankind. Here we report binding index of 305 HLA class I …

[HTML][HTML] BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans

…, M Bexon, S Bolte, T Palanche, A Schultz, S Baumann… - Nature, 2021 - nature.com
BNT162b2, a nucleoside-modified mRNA formulated in lipid nanoparticles that encodes the
SARS-CoV-2 spike glycoprotein (S) stabilized in its prefusion conformation, has …

BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans

…, M Bexon, S Bolte, T Palanche, A Schultz, S Baumann… - MedRxiv, 2020 - medrxiv.org
… -specific CD4 + T cells producing the indicated cytokine as a fraction of total cytokine-producing
S-specific CD4 + T cells in response to S pool 1 and S pool 2. CD4 non-responders (<…